Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4645815
Max Phase: Preclinical
Molecular Formula: C52H68N10O8S
Molecular Weight: 993.24
Molecule Type: Unknown
Associated Items:
ID: ALA4645815
Max Phase: Preclinical
Molecular Formula: C52H68N10O8S
Molecular Weight: 993.24
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CCCCN(Cc1ccc(C(=O)NO)cc1)C(=O)Nc1ccc(OCCCCn2cc(CCCCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCc3ccc(-c4scnc4C)cc3)C(C)(C)C)nn2)cc1
Standard InChI: InChI=1S/C52H68N10O8S/c1-6-7-26-60(31-37-16-20-39(21-17-37)48(65)58-69)51(68)55-40-22-24-43(25-23-40)70-28-11-10-27-61-32-41(57-59-61)12-8-9-13-45(64)56-47(52(3,4)5)50(67)62-33-42(63)29-44(62)49(66)53-30-36-14-18-38(19-15-36)46-35(2)54-34-71-46/h14-25,32,34,42,44,47,63,69H,6-13,26-31,33H2,1-5H3,(H,53,66)(H,55,68)(H,56,64)(H,58,65)/t42-,44+,47-/m1/s1
Standard InChI Key: DEVICSQKDYWDSP-OLBZIVSESA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 993.24 | Molecular Weight (Monoisotopic): 992.4942 | AlogP: 7.04 | #Rotatable Bonds: 24 |
Polar Surface Area: 233.24 | Molecular Species: NEUTRAL | HBA: 13 | HBD: 6 |
#RO5 Violations: 4 | HBA (Lipinski): 18 | HBD (Lipinski): 6 | #RO5 Violations (Lipinski): 4 |
CX Acidic pKa: 9.05 | CX Basic pKa: 2.65 | CX LogP: 5.23 | CX LogD: 5.22 |
Aromatic Rings: 5 | Heavy Atoms: 71 | QED Weighted: 0.02 | Np Likeness Score: -1.10 |
1. Yang K, Wu H, Zhang Z, Leisten ED, Nie X, Liu B, Wen Z, Zhang J, Cunningham MD, Tang W.. (2020) Development of Selective Histone Deacetylase 6 (HDAC6) Degraders Recruiting Von Hippel-Lindau (VHL) E3 Ubiquitin Ligase., 11 (4): [PMID:32292566] [10.1021/acsmedchemlett.0c00046] |
Source(1):